Treatment of natalizumab‐associated PML with filgrastim

OBJECTIVE: There is no consensus on the treatment of progressive multifocal leukoencephalopathy (PML) occurring in multiple sclerosis (MS) patients treated with natalizumab (Nz). We report novel immune activating treatment with filgrastim of Nz‐associated PML in MS patients treated at Rush Universit...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefoski, Dusan, Balabanov, Roumen, Waheed, Rasha, Ko, Michael, Koralnik, Igor J., Sierra Morales, Fabian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529830/
https://www.ncbi.nlm.nih.gov/pubmed/31139690
http://dx.doi.org/10.1002/acn3.776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529830/
https://www.ncbi.nlm.nih.gov/pubmed/31139690
http://dx.doi.org/10.1002/acn3.776

Ejemplares similares